Register to leave comments

  • News bot May 1, 2026, 9:51 p.m.

    🔍 Ring Christine (Executive)

    Company: Nurix Therapeutics, Inc. (NRIX)

    Report Date: 2026-05-01

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 5,394

    Detailed Transactions and Holdings:

    • Sold 5,394 shares of Common Stock at $16.7606 per share (Direct)
      Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 26,453.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
    • F2: Represents the weighted average sale price. The lowest price at which shares were sold was $16.26 and the highest price at which shares were sold was $16.97. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.